STAT3 as a predictive biomarker in head and neck cancer: A validation study.

van Ruitenbeek, N J; van der Woude, L L; van Krieken, J H; van Engen-van Grunsven, A C H; Willemsen, A E C A B; van Herpen, C M L

van Ruitenbeek, N J; van der Woude, L L; van Krieken, J H; van Engen-van Grunsven, A C H; Willemsen, A E C A B; van Herpen, C M L.

Affiliation

van Ruitenbeek NJ; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10 Nijmegen, the Netherlands. Electronic address: niels.vanruitenbeek@radboudumc.nl.
van der Woude LL; Department of Pathology, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen, the Netherlands.
van Krieken JH; Department of Pathology, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen, the Netherlands.
van Engen-van Grunsven ACH; Department of Pathology, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen, the Netherlands.
Willemsen AECAB; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10 Nijmegen, the Netherlands.
van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10 Nijmegen, the Netherlands.

Pathol Res Pract ; 216(11): 153172, 2020 Nov.

Article de En | MEDLINE | ID: mdl-32858373

Sujet(s)
Mots clés

Biomarker; Cisplatin; Head and neck cancer; Radiotherapy; STAT3

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Marqueurs biologiques tumoraux / Facteur de transcription STAT-3 / Tumeurs de la tête et du cou Type d'étude: Observational_studies / Prognostic_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Pathol Res Pract Année: 2020 Type de document: Article Pays de publication: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google